This group initially hypothesised those inflammatory mediators such as IL-6 may produce central hypogonadism by up-regulating adipose aromatase activity, with the resulting estradiol reducing pituitary LH drive for testosterone production, since pro-inflammatory cytokines are known inducers of aromatase action. The gene discussed is PLOD1; the disease is hypogonadotropic hypogonadism.